Korean Botulinum toxin type A (KbtxA) and Botox injection
Phase 3Completed 0 watching 0 views this week📈 Rising
69
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedIndication / Disease
Blepharospasm
Conditions
Blepharospasm
Trial Timeline
Oct 1, 2005 → Aug 1, 2006
NCT ID
NCT00682760About Korean Botulinum toxin type A (KbtxA) and Botox injection
Korean Botulinum toxin type A (KbtxA) and Botox injection is a phase 3 stage product being developed by Pacific Biosciences for Blepharospasm. The current trial status is completed. This product is registered under clinical trial identifier NCT00682760. Target conditions include Blepharospasm.
Hype Score Breakdown
Clinical
27
Activity
18
Company
2
Novelty
9
Community
10
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00682760 | Phase 3 | Completed |
Competing Products
2 competing products in Blepharospasm
| Product | Company | Stage | Hype Score |
|---|---|---|---|
| Botulinum toxin type A | Ipsen | Phase 2 | 49 |
| Dipraglurant + Placebo | Addex Therapeutics | Phase 2 | 44 |